2024

“Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells”
Esquea EM, Ciraku L, Young RG, Merzy J, Talarico AN, Ahmed NN, Karuppiah M, Ramesh A, Chatoff A, Crispim CV, Rashad AA, Cocklin S, Snyder NW, Beld J, Simone NL, Reginato MJ, Dick A
Front Pharmacol. 2024 May 16;15:1394685

2023

“Fructose promotes liver cancer via microbial acetate-induced O-GlcNAcylation”
Esquea EM, Young RG, and Reginato MJ
Trends in Endocrinology & Metabolism, 2023 Dec 13:S1043-2760 (23)00247-3

“On a sugar high: Role of O-GlcNAcylation in cancer”
Le Minh, G, Esquea EM, Young RG, Huang, J, and Reginato MJ
Journal of Biological Chemistry, 2023 Oct 12, 105344

“Kruppel-like factor 8 regulates triple negative breast cancer stem cell-like activity”
Le Minh G, Esquea EM, Dhameliya TT, Merzy J, Lee MH, Ball LE, Reginato MJ
Frontiers in Oncolology. 2023 Apr 19;13:1141834

“Role of O-GlcNAcylation on cancer stem cells: Connecting nutrient sensing to cell plasticity”
Le Minh G, Reginato MJ
Advanced Cancer Research. 2023;157:195-228

2022

“O-GlcNAc Transferase Regulates Glioblastoma Acetate Metabolism via Regulation of CDK5-dependent ACSS2 phosphorylation”
Ciraku, L., Bacigalupa, Z. A., Ju, J., Moeller, R. A., Le Minh, G., Lee, R. H., Smith, M. D., Ferrer, C. M., Trefely, S., Izzo, L. T., Doan, M. T., Gocal, W. A., D'Agostino, L., Shi, W., Jackson, J. G., Katsetos, C. D., Wellen, K. E., Snyder, N. W., and Reginato, M. J.
Oncogene 2022 Apr;41(14):2122-2136

“O-GlcNAcylation regulation of cellular signaling in cancer”
Ciraku, L., Esquea, Reginato, M. J.
Cellular Signaling 2022 Nov 17;90

2021

“An ex vivo brain slice model to study and target breast cancer brain metastatic tumor growth”
Ciraku, L., Moeller, R., Esquea, Gocal, W., Hartsough, E., Simone, N., Jackson, J., Reginato, M. J.
Journal Visualized Experiments 2021 Sep 22; (175)

“Role of hexosamine biosynthetic pathway on cancer stem cells: Connecting nutrient sensing to cancer cell plasticity”
Le Minh, G. and Reginato, M. J.
Comprehensive Pharmacology. 2021 Elsevier, Elizabeth Yeh (ed.)

2020

“O-GlcNAc Transferase Regulates Cancer Stem-like Potential of Breast Cancer Cells”
Akella NM, Le Minh G, Ciraku L, Mukherjee A, Bacigalupa ZA, Mukhopadhyay D, Sodi VL, Reginato MJ
Molecular Cancer Research 2020 Apr;18(4):585-598

2019

"Breast cancer brain metastasis response to radiation following microbubble oxygen delivery in a murine model"
Delaney L, Ciraku L, Oeffinger B, Wessner C, Liu J, Li J, Nam K, Forsberg F, Leeper D, O'Kane P, Wheatley M, Reginato MJ, Eisenbrey J
Journal of Ultrasound in Medicine 2019 Dec;38(12):3221-3228.

“Fueling the Fire: Emerging Role of the Hexosamine Biosynthetic Pathway in Cancer”
Akella NM, Ciraku L, and Reginato MJ
BMC Biology 2019 Jul 4;17(1):52

2018

"O-GlcNAcylation: key regulator of glycolytic pathways"
Bacigalupa ZA, Bhadiadra C, and Reginato MJ
Journal of Bioenergetics and Biomembranes 2018 Jun;50(3):189-198

2017

"Nutrient sensor O-GlcNAcylation controls cancer lipid metabolism via SREBP-1 regulation"
Sodi VL, Bacigalupa ZA, Ferrer CM, Lee J, Gocal W, Mukherjee D, Wellen KE, Ivan M, and Reginato MJ
Oncogene. 2017 Oct 23 [Epub ahead of print]

"Metabolite profiling reveals the glutathione biosynthetic pathway as a therapeutic target in triple negative breast cancer"
Beatty A, Fink LS, Singh T, Strigun A, Peter E, Ferrer CM, Nicolas E, Cai KQ, Moran TP, Reginato MJ, Rennefahrt U, Peterson JR.
Molecular Cancer Therapeutics. 2017 Oct 11 [Epub ahead of print]

"The addition of calcitriol or its synthetic analog EB1089 to lapatinib and neratinib treatment inhibits cell growth and promotes apoptosis in breast cancer cells."
Segovia-Mendoza M, Díaz L, Prado-Garcia H, Reginato MJ, Larrea F and García-Becerra R
Am J Cancer Research. Jul 1 2017;7(7):1486-1500.

2016

"Proapoptotic protein Bim attenuates estrogen-enhanced survival in lymphangioleiomyomatosis"
Li C, Li N, Liu X, Zhang EY, Sun Y, Masuda K, Li J, Sun J, Morrison T, Li X, Chen Y, Wang J, Karim NA, Zhang Y, Blenis J, Reginato MJ, Henske EP, Yu JJ.
J. of Clinical Investigation Insight; 1(19): e86629, Nov 17, 2016

"O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FoxM1 pathway"
Ferrer CM, Lu TY, Bacigalupa ZA, Katsetos CD, Sinclair DA, and Reginato, MJ
Oncogene, Jun 27 2016 [Epub ahead of print]

"O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling"
Ferrer CM, Sodi VL and Reginato MJ
Journal of Molecular Biology, Jun 22 2016 [Epub ahead of print](add link)

2015

"Progress towards overcoming hypoxia-induced resistance to solid tumor therapy"
Karakashev SV, and Reginato MJ
Cancer Management and Research, 12;7:253-64 Aug 2015

"Emerging microtubule targets in glioma therapy"
Katsetos CD, Reginato MJ, Baas PW, D’Agostino L, Legido A, Tuszyn Ski JA, Draberova E, and Draber P
Seminars in Pediatric Neurology; 22(1):49-72, March 2015

"mTOR/c-MYC axis regulates O-GlcNAc transferase (OGT) expression and O-GlcNAcylation in breast cancer"
Sodi VL, Khaku S, Schwab LP, Vocadlo DJ, Seagroves TN and Reginato MJ
Molecular Cancer Research, 13(5):923-33, May 2015
Publication listed in Highlights of This Issue

"Epithelial-to-mesenchymal transition alters interstitial fluid flow-induced signaling in ERBB2-positive breast cancer cells"
Tchafa AM, Ta M,  Reginato MJ and Shieh AC
Molecular Cancer Research, 13(4):755-64, Apr 2015

"Hypoxia/HIF-1a induces lapatinib resistance in ERBB2-positive breast cancer cells via regulation of DUSP2"
Karakashev SV, and Reginato MJ
Oncotarget, 6(4):1967-80, Feb 10, 2015

2014

"Sweet Connections: O-GlcNacylation links cancer metabolism and survival"
Ferrer CM, and Reginato MJ
Molecular & Cellular Oncology, Oct 29; 2(1) 2014

Book Chapter: "Cancer Metabolism: Cross Talk Between Signaling and O-GlcNAcylation"
Ferrer CM, and Reginato MJ
Cancer Genomics and Proteomics: Methods and Protocols, Methods in Molecular Biology, Vol. 1176 pp 73-88, Springer, Narendra Wajapeyee (Ed.), 2014

"O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of HIF-1 pathway"
Ferrer CM, Lynch TP, Sodi V, Falcone JN, Schwab L, Peacock D, Vocadlo DJ, Seagroves TN, and Reginato MJ 
Molecular Cell; (54(5); 820-831, June 5, 2014

"Sticking to Sugars at the Metastatic Site: Sialyltransferase ST6GalNAc2 Acts as Breast Cancer Metastasis Suppressor"
Ferrer, CM, and Reginato, MJ
Cancer Discovery; March 4(3); 275–7, March 2014

"Activated ERBB2/HER2 licenses sensitivity to apoptosis upon endoplasmic reticulum stress through a PERK-dependent pathway"
Martin-Perez, R, Palacios, C, Yerbes, R, Cano-Gonzales, A, Iglesias-Serret, D, Gil, J, Reginato, MJ and López-Rivas A  
Cancer Research; 74(6): 1766-77, March 15, 2014

"ErbB2, FoxM1, and 14-3-3ζ prime breast cancer cells for invasion in response to ionizing radiation"
Kambach DM, Sodi VL, Lelkes PI, Azizkhan-Clifford J, and Reginato MJ 
Oncogene Jan 30; 33(5):589-98 (2014)

2013

"HINCUTs in Cancer: Hypoxia-induced non-coding ultraconserved transcripts"
Ferdin J, Wu X, Nishida N Nicoloso MS, Shah NM, Devlin C, Ling H, Shimizu M, Kumar K, Cortez MA, Ferracin M, Bi Y, Yang D, Czerniack BA, Zhang W, Schmittgen TD, Voorhoeve MP, Reginato MJ, Negrini M, Davuluri RV, Kunej T, Iva, M, and Calin GA
Cell Death Differ Sep 13 2013 [Epub ahead of print]

"The oncogene HER2/neu (erbB2) requires the Hypoxia-inducible factor HIF-1 for mammary tumor growth and anoikis resistance"
Whelan KA, Schwab L, Karakashev S, Franchetti L, Johannes GJ, Seagrove, TN, and  Reginato MJ
J. Biol Chem May 31; 288(22):15865-77 (2013)

"ERK2 regulated TIMP1 induces hyperproloferation of K-Ras (G12D)-transformed pancreatic ductal cells"
Botta GP, Reichert M, Reginato MJ, Heeg S, Rustgi AK and Lelkes PI
Neoplasia Apr 15 (4): 359-72 (2013)

2012

"Control of FLIPL expression and TRAIL resistance by the extracellular signal regulated kinase (ERK)1/2 pathway in breast epithelial cells"
Yerbes R, López-Rivas A, Reginato MJ, and Palacios C
Cell Death Differ; 19:1908-16, Dec 2012

"Critical role of O-GlcNAc transferase in prostate cancer invasion, angiogenesis, and metastasis"
Lynch TP, Ferrer C, Jackson SR, Shahriari KS, Vosseller K, and Reginato MJ 
J. Biol. Chem. Mar 30; 287: 11070-81 (2012)

"Constitutive K-Ras activation of ERK2 in a three-dimensional model of human pancreatic cells regulates invasion via induction of matrix metalloproteinase-1"
Botta, GP, Reginato, MJ, Rustgi, AK, and Lelkes, PI
Mol. Cancer Research, Feb; 10: 183-96. (2012)

2011

"Surviving without oxygen: Hypoxia regulation of mammary morphogenesis and anoikis"
Whelan, KA and Reginato, MJ
Cell Cycle Jul 15: 10, 2287-94 (2011)

"Cellular FLIP(L) plays a survival role and regulates morphogenesis in breast epithelial cells"
Yerbes, R, Palacios, C, Reginato, MJ, and Lopez-Rivas, A
Biochim Biophys Acta Jan: 1813, 168-78 (2011)

"O-GlcNAc transferase: A sweet new cancer target"
Lynch, TP and Reginato, MJ
Cell Cycle June 1: 10, 1712-13 (2011)

2010

"Hypoxia suppression of Bim and Bmf blocks anoikis and luminal clearing during mammary morphogenesis"
Whelan, KA, Caldwell, SA, Shahriari, KS, Jackson, SR, Jones, L, Johannes, G and Reginato, MJ
Mol. Biol. Cell. Nov 15: 21, 3829-37 (2010)

"Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis via targeting of the oncogenic transcription factor FoxM1"
Caldwell, SA, Jackson, SR, Shahriari, KS, Lynch, TP, Sethi, G, Walker, S, Vosseller, K, and Reginato, MJ
Oncogene May 13: 29, 2831-42 (2010)

"ErbB2 requires integrin alpha5 for anoikis resistance via c-Src regulation of receptor activity in human mammary epithelial cells"
Haenssen, KK, Caldwell, SA, Shahriari, K, Jackson, R, Whelan, K, Klein-Szanto, A, and Reginato, MJ
J. of Cell Science  April 15: 123, 1373-82 (2010)

 
 Back to Top